Quarterly ResultAug 13, 2026, 04:14 PM
cbdMD Q3 Net Loss $(1.13M), Sales Up; Going Concern Warning
AI Summary
cbdMD, Inc. reported a net loss of $(1,127,202) for the three months ended June 30, 2026, and $(2,208,315) for the nine months ended June 30, 2026. Despite an increase in net sales to $5,553,738 for the quarter and $16,210,701 for the nine months, the company issued a going concern warning due to continued losses and the need for additional funding. The company also completed an all-stock acquisition of Bluebird Botanicals and saw an increase in cash and cash equivalents.
Key Highlights
- Substantial doubt about the Company's ability to continue as a going concern.
- Net sales increased to $5,553,738 for Q3 2026, up from $4,606,796 in Q3 2025.
- Net loss attributable to common shareholders improved to $(1,198,233) in Q3 2026 from $(1,228,772) in Q3 2025.
- Basic and diluted EPS improved to $(0.11) in Q3 2026 from $(0.21) in Q3 2025.
- Acquired Bluebird Botanicals in an all-stock deal valued at $936,992.
- Cash and cash equivalents increased to $2,118,339 as of June 30, 2026.
- Wholesale sales grew to 30.3% of total net sales for the nine months ended June 30, 2026.
Price Impact
More from YCBD